161 related articles for article (PubMed ID: 5566728)
1. Narcotic antagonists in the treatment of opiate dependence.
Fink M; Zaks A; Resnick RB; Freedman AM
Int Z Klin Pharmakol Ther Toxikol; 1971 Jun; 4(4):455-8. PubMed ID: 5566728
[No Abstract] [Full Text] [Related]
2. Pharmacological approaches to the treatment of morphine-type dependence.
Halbach H
Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):6-12. PubMed ID: 1165143
[TBL] [Abstract][Full Text] [Related]
3. Blockade with methadone, cyclazocine, and naloxone.
Freedman AM; Zaks A; Resnick R; Fink M
Int J Addict; 1970 Sep; 5(3):507-15. PubMed ID: 5524385
[No Abstract] [Full Text] [Related]
4. [Management of opium addicts using opiates and their antagonists].
Burchard JM
Nervenarzt; 1972 Oct; 43(10):501-4. PubMed ID: 4564819
[No Abstract] [Full Text] [Related]
5. Synthetic 14-hydroxymorphinan narcotic antagonists.
Pachter IJ
Adv Biochem Psychopharmacol; 1973; 8(0):57-62. PubMed ID: 4153098
[No Abstract] [Full Text] [Related]
6. Cyclazocine in the treatment of narcotic addiction.
Jaffe JH
Curr Psychiatr Ther; 1967; 7():147-56. PubMed ID: 4860298
[No Abstract] [Full Text] [Related]
7. Certain theoretical and practical considerations involved in evaluating the overall abuse potential of opiate agonists and antagonists.
Fraser HF
Adv Biochem Psychopharmacol; 1973; 8(0):439-53. PubMed ID: 4604198
[No Abstract] [Full Text] [Related]
8. Cyclazocine treatment of opiate dependence: a progress report.
Resnick RB; Fink M; Freedman AM
Compr Psychiatry; 1971 Nov; 12(6):491-502. PubMed ID: 5117068
[No Abstract] [Full Text] [Related]
9. Clinical pharmacology of mixed agonist-antagonist drugs [proceedings].
Jasinski DR
Psychopharmacol Bull; 1981 Jan; 17(1):85-6. PubMed ID: 7232665
[No Abstract] [Full Text] [Related]
10. Addiction and the community. (Narcotic substitution therapy).
Taylor WJ; Chambers CD; Bowling CE
Int J Clin Pharmacol; 1972 Apr; 6(1):28-39. PubMed ID: 4625924
[No Abstract] [Full Text] [Related]
11. Intravenous diacetylmorphine (heroin) in studies of opiate dependence.
Zaks AM; Bruner A; Fink M; Freedman AM
Dis Nerv Syst; 1969 Feb; 30(2):Suppl:89-92. PubMed ID: 4886996
[No Abstract] [Full Text] [Related]
12. Methadone maintenance and narcotic blocking drugs. Appendix.
Wikler A
Int J Addict; 1977 Oct; 12(7):869-81. PubMed ID: 338517
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacologic aspects of the treatment of drug addiction due to morphine-like substances].
Babaian EA; Bulaev VM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(1):134-9. PubMed ID: 2566216
[No Abstract] [Full Text] [Related]
14. [The effect of GABA-positive agents on the formation of morphine dependence and on the manifestations of a withdrawal syndrome].
Belozertseva IV; Andreev BV
Eksp Klin Farmakol; 2000; 63(1):19-23. PubMed ID: 10763104
[TBL] [Abstract][Full Text] [Related]
15. The use of drugs in the management of drug dependence.
Eddy NB
J Tenn Med Assoc; 1967 Mar; 60(3):269-73. PubMed ID: 6042204
[No Abstract] [Full Text] [Related]
16. Narcotic antagonists in opiate dependence.
Fink M
Science; 1970 Sep; 169(3949):1005-6. PubMed ID: 4914724
[No Abstract] [Full Text] [Related]
17. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
[TBL] [Abstract][Full Text] [Related]
18. A cyclazocine typology in opiate dependence.
Resnick RB; Fink M; Freedman AM
Am J Psychiatry; 1970 Mar; 126(9):1256-60. PubMed ID: 5413202
[No Abstract] [Full Text] [Related]
19. [Treatment of opiate withdrawal syndromes (historical review)].
Jeziorski K; Matsumoto H
Pol Tyg Lek; 1984 Oct; 39(43):1433-6. PubMed ID: 6151173
[No Abstract] [Full Text] [Related]
20. Narcotic antagonists. Treatment tool for addiction.
Valentine NM; Meyer RE
Nurs Clin North Am; 1976 Sep; 11(3):541-9. PubMed ID: 785400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
